top of page

BMO Capital Markets’ Evan Seigerman joins BiotechTV for Analyst Thursdays

  • blonca9
  • Aug 31, 2023
  • 1 min read

Evan Seigerman gives his take on biotech and discusses the Medicare negotiation list, Lilly, Amgen, Skyscraper-01, Structure Therapeutics, Disc Medicine, Replimune, and other upcoming catalysts.




Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent logo_tagline.png

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

bottom of page